2003American Journal of Health-System PharmacyRequires access

Role of i.v. allopurinol and rasburicase in tumor lysis syndrome

Author information unavailable

Open publisher page 1 citations

Abstract

Journal Article Role of i.v. allopurinol and rasburicase in tumor lysis syndrome Get access American Journal of Health-System Pharmacy, Volume 60, Issue 21, 1 November 2003, Pages 2223–2224, https://doi.org/10.1093/ajhp/60.21.2223 Published: 01 November 2003

About this research paper

What this paper is about

Journal Article Role of i.v. allopurinol and rasburicase in tumor lysis syndrome Get access American Journal of Health-System Pharmacy, Volume 60, Issue 21, 1 November 2003, Pages 2223–2224, https://doi.org/10.1093/ajhp/60.21.2223 Published: 01 November 2003

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Journal Article Role of i.v. allopurinol and rasburicase in tumor lysis syndrome Get access American Journal of Health-System Pharmacy, Volume 60, Issue 21, 1 November 2003, Pages 2223–2224, https://doi.org/10.1093/ajhp/60.21.2223 Published: 01 November 2003

Key concepts: Rasburicase, Tumor lysis syndrome, Allopurinol, Lysis, Pharmacy, Medicine, Internal medicine, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
Role of i.v. allopurinol and rasburicase in tumor lysis syndrome — Research Paper | ScholarLens